Atherosclerosis risk factors related to hemodialysis duration and erythropoietin therapy. (Record no. 11431446)

MARC details
000 -LEADER
fixed length control field 01429 a2200433 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514005325.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200202s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1434-6621
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1515/CCLM.2001.079
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Dejanova, B
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20020208
245 00 - TITLE STATEMENT
Title Atherosclerosis risk factors related to hemodialysis duration and erythropoietin therapy.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical chemistry and laboratory medicine
Date of publication, distribution, etc. Jun 2001
300 ## - PHYSICAL DESCRIPTION
Extent 484-6 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Arteriosclerosis
General subdivision etiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Case-Control Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Erythropoietin
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lipid Peroxidation
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lipids
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recombinant Proteins
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Renal Dialysis
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Time Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Triglycerides
General subdivision blood
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Filipce, V
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dejanov, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sikole, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Grozdanovski, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Maleska, V
773 0# - HOST ITEM ENTRY
Title Clinical chemistry and laboratory medicine
Related parts vol. 39
-- no. 6
-- p. 484-6
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1515/CCLM.2001.079">https://doi.org/10.1515/CCLM.2001.079</a>
Public note Available from publisher's website

No items available.